Vicarious Surgical demonstrates Beta 2 surgical robot platform
Evidence notes
- Vicarious Surgical hosted an investor day and demonstrated its Beta 2 surgical robot platform.
- The demonstration showed the company''s compact patient-side approach to minimally invasive robotic surgery.
- The milestone is development evidence, not evidence of broad commercial deployment.
Company context
Vicarious Surgical is developing a surgical robotics platform intended to provide minimally invasive access through a compact, patient-side robotic system.